Johnson & Johnson

09/13/2021 | Press release | Distributed by Public on 09/13/2021 16:31

Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune Response in Adults and Children in Data Published in The Lancet Infectious Diseases